LCMS
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike

Pharmaceutical Analysis using UV-Vis: Compliance with Supplement I to the Japanese Pharmacopoeia 18th Ed., Section 2.24

Technical notes | 2021 | Agilent TechnologiesInstrumentation
Software, UV–VIS spectrophotometry
Industries
Pharma & Biopharma
Manufacturer
Agilent Technologies

Summary

Importance of the Topic


UV-Vis spectroscopy is essential in pharmaceutical QA/QC and research because it provides rapid, reliable measurements for active ingredients and impurities. Compliance with pharmacopoeial guidelines ensures data accuracy and regulatory acceptance.

Objectives and Overview


This paper evaluates the Agilent Cary 3500 UV-Vis spectrophotometer’s system verification tests in accordance with Supplement I to the Japanese Pharmacopoeia 18th Edition, Section 2.24. It highlights automated workflows that facilitate compliance.

Methodology


The study implements key tests specified by the JP: wavelength accuracy and precision, photometric accuracy and precision, and photometric linearity. Certified reference materials include rare earth oxide solutions (holmium, didymium, cerium), NIST-traceable glass filters, and potassium dichromate standards. Each test involves multiple replicates and is evaluated against JP tolerance criteria.

Used Instrumentation


The Agilent Cary 3500 UV-Vis spectrophotometer features a multicell module with eight cuvette positions enabling simultaneous reference and sample measurements. The system is controlled by Cary UV Workstation software, which automates instrument qualification routines.

Main Results and Discussion


All system verification tests passed JP acceptance limits: wavelength accuracy within ±0.5 nm and precision better than 0.2 nm; photometric accuracy within ±0.002 Abs (below 0.500 Abs) and ±0.004 Abs (above 0.500 Abs); and linearity coefficients exceeding 0.999. The multicell design and variable spectral bandwidth (0.1–5.0 nm) support robust performance across the UV-Vis range.

Benefits and Practical Applications


  • Automated qualification saves time and minimizes manual errors.
  • Simultaneous measurements improve throughput and data consistency.
  • Flexible software allows custom test lists and supports cGMP documentation.

Future Trends and Potential Applications


Advances may include integration with laboratory information management systems, expanded spectral range for emerging assays, and application of AI-driven analytics for real-time QC. Enhanced data integrity features will support compliance with evolving regulations such as 21 CFR Part 11 and EU Annex 11.

Conclusion


The Agilent Cary 3500 UV-Vis spectrophotometer, combined with automated Cary UV Workstation software, provides an efficient, compliant solution for pharmaceutical instrument qualification according to Japanese Pharmacopoeia requirements. It ensures high performance, data integrity, and streamlined workflows.

Content was automatically generated from an orignal PDF document using AI and may contain inaccuracies.

Downloadable PDF for viewing
 

Similar PDF

Toggle
Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25)
Application Note Pharmaceutical Analysis Using UV-Vis: Compliance with USP Chapter <857>, and European Pharmacopoeia (Ph. Eur. Chapter 2.2.25) Meeting the requirements of the global pharmacopeias with the Agilent Cary 3500 UV-Vis Introduction UV-Vis spectroscopy is a widely used analytical technique…
Key words
absorbance, absorbancewavelength, wavelengthphotometric, photometricstray, straylight, lightpositions, positionsholmium, holmiumvis, viscontrol, controltest, testrecommended, recommendedreference, referencetolerances, tolerancestests, testsdidymium
Spectroscopy Solutions for Pharmaceuticals
Spectroscopy Solutions for Pharmaceuticals
2016|Agilent Technologies|Technical notes
Spectroscopy Solutions for Pharmaceuticals: Confidence in Compliance to USP <857> Using the Agilent Cary 60 UV-Vis Spectrophotometer White Paper Introduction UV-Vis spectroscopy is one of the most commonly used analytical techniques in clinical chemistry, pharmaceutical research, and quality control/quality assurance…
Key words
winuv, winuvcary, carystray, straywavelength, wavelengthphotometric, photometricvalidate, validatespectrophotometer, spectrophotometeraccuracy, accuracyabsorbance, absorbancetests, testsvis, vislight, lightprecision, precisiontest, testwavelengths
UV-VISIBLE HARDWARE OPERATIONAL QUALIFICATION
UV-VISIBLE HARDWARE OPERATIONAL QUALIFICATION
2012|Agilent Technologies|Others
UV-VISIBLE HARDWARE OPERATIONAL QUALIFICATION Agilent Enterprise Edition Compliance Services Standard OQ Test Specifications for UV-Visible Spectrophotometers The following tables describe the core hardware testing specifications for UV-Visible systems. See the corresponding attachment for a description of the optional tests available…
Key words
spectrophotometers, spectrophotometersrationale, rationalevisible, visibletest, testenterprise, enterpriseedition, editionaccuracy, accuracycontinued, continueddesign, designsetpoints, setpointsservices, serviceslimits, limitscompliance, compliancewavelength, wavelengthmodels
USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition
USP General Chapter <857> and Ph. Eur. Chapter 2.2.25 10th Edition Meeting requirements with the Cary 60 and Cary 3500 UV-Vis spectrophotometers Qualification of instruments Updates to the United States Pharmacopeia (USP) General Chapter <857> and the European Pharmacopoeia (Ph.…
Key words
qualification, qualificationphotometric, photometricsodium, sodiumpotassium, potassiumspectrophotometers, spectrophotometersiodide, iodidenitrate, nitratedidymium, didymiumvis, visabsorbance, absorbancetest, testservices, servicesacetone, acetoneaccuracy, accuracyelectronic
Other projects
GCMS
ICPMS
Follow us
More information
WebinarsAbout usContact usTerms of use
LabRulez s.r.o. All rights reserved. Content available under a CC BY-SA 4.0 Attribution-ShareAlike